Latest

2008 global conference on methamphetamine: science, strategy, and response        prague, september 15 – 16

<http://www.globalmethconference.com>

 

Abstract Submission Deadline ENDS April 22nd, 2008

 

Abstract Submission Guidelines

Topics and areas to be discussed include
 
Regional Updates  / Pharmacology / Enforcement Programs  / Clandestine Drug Cleanup / The Matrix Model of Treatment / Women and Methamphetamine / Latest Research /Health Consequences /  Policy  / Prosecution Issues / Trafficking / Toxicology / Innovative Interventions / Replacement Therapies / Prevention and Education / Hepatitis A, B, & C Virus / HIV Risk Behavior / Methamphetamine and Reproductive Health / Treatment / Youth and Use / Patterns of Use / Harm Reduction / innovative Interventions / Use Among MSM / Trafficking  / Community-based Coalitions / Injection Drug Use / Epidemiology

1) Individual proposals for presentations are welcome.
 
2) Presentation formats may include
 
Individual papers
    Reports on research-in-progress

    Round-table discussions

    Topic-centred workshops

    Or a format more appropriate to your own work.

- Please indicate your presentation format in your proposal.
- Please make sure that your proposal identifies the language you wish to present in.
 
3) Please send a 250-word proposal - along with a short bio - to the email address below.
 
- Your abstract should not contain more than 250 words
- No abstract will be accepted without a short bio.
 
Please send your abstract to [email protected]

The Deadline for abstract submissions is April 22, 2008
Speakers will be notified by May 2nd, 2008
 
Do you have a question or concern?

 Please feel free to contact me at [email protected]
--

Luciano Colonna
Chair
Executive Program Committee

2008 Global Conference on Methamphetamine
September 15 –16, 2008 - Prague, Czech Republic
www.globalmethconference.com

[email protected]
+00 (1) 801 635 7736 (USA mobile)
+44 (0) 208 987 6021 (London tell)
+44 (0) 208 994 1533 (London fax)
lucianocolonna (skype)

[Courtesy of Americans for Safe Access]

Dear ASA Supporter,

Dr. Abrams has conducted numerous groundbreaking medical marijuana studies and you could be involved in his next historic project! Time is of the essence, be one of two dozen people to impact medical marijuana research for the future.

In order to ensure that this necessary research continues and is a success, Dr. Abrams is seeking out individuals who meet the following qualifications:

To qualify, you must:

Be taking either OxyContin or MS Contin (or Kadian) twice daily;

Have smoked marijuana at least 6 times in the past;

Be willing NOT to smoke marijuana for a month prior to screening for the study;

Be willing not to smoke cigarettes at least 2 weeks prior to screening and through the study;

Be 18 years or older;

Meet some additional criteria;

And you cannot:

Be pregnant, trying to become pregnant, or breastfeeding;

Be on chemo, radiation, or other cancer therapy;

Be currently using alcohol or recreational drugs;

Have kidney or liver failure, severe heart problems, high blood pressure, lung disease or a severe psychiatric disorder.

The study takes place at San Francisco General Hospital, in the clinical research center, and is a 5-day inpatient stay. Participants may be eligible to receive up to $520.00 for travel reimbursements. You can read more about the study here: www.AmericansforSafeAccess.org/AbramsPainStudy

How to Get Involved:
If you meet the qualifications above and are interested in participating in this historical research please contact Paul Couey at: 415-476-9554 ext 315 or e-mail at: [email protected]. Let Paul know you found out about this study from ASA.

If you do not meet the criteria above, there is still an important role for you to play! Please forward this message on to any lists you belong to, any community members you know might be interested, and your family and friends!

Sincerely,

Sonnet Seeborg Gabbard
Field Coordinator
Americans for Safe Access